How Sustainable Is Your Medicine? Spain Now Prices It In | Nerea Blanque Catalina | EP 10

Green HTA, Spain's world-first sustainability-linked drug pricing, and why the US freeloads too: on this episode of The Pharma Perspective, pricing and market access expert Nerea Blanque Catalina explains how sustainability is becoming a real factor in what payers pay for medicines. Nerea breaks down Spain's brand-new policy giving green efforts a 10–20% weight in pricing and reimbursement negotiations, how pharma companies can prove sustainability at product level, and how Novo Nordisk turned recycled syringes into office furniture. She also unpacks MFN's ripple effects on confidential net prices in Europe, the IRA and what the US midterms could mean for drug pricing, and her "salami" approach to price negotiations, before closing on the joke LinkedIn post that turned into a real book. Essential viewing for anyone in pharma, market access, HEOR, health policy, or life sciences.